StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Record Time

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon Nov 27, 2021 4:07pm

135 Views

Post# 34172576

RE:RE:RE:RE:Record Time

But thats exactly what they did.

Of course the PP had to be pretty much finalized before the stock ran. Nothing gets done that quickly. So what was the deal did HC think that one news release was going to prop it up to the amount they agreed the PP to be or was the PP agreed at a higher evaluation anyway?

I will admit the more cities the better for them to be in but how did that one news release send the SP up 100%. It obvious Stage must had some hand in proping that up all due ot the PP that would be released.

Just seems like a whole lot of funny business going on and again shareholds are left to ponder what is really going on.

#tranparency.

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks